Status:
TERMINATED
Early Rehabilitation for Breast Cancer - A Randomized Control Trial
Lead Sponsor:
University of South Carolina
Collaborating Sponsors:
Prisma Health-Midlands
Conditions:
Neoplasms, Breast
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Upper extremity strength, range of motion, activity limitations, fatigue and pain are well-documented concerns for women receiving treatment for breast cancer. Research has shown that cancer-related t...
Detailed Description
The overall objective of this study is to examine the impact of employing early rehabilitation by implementing a randomized controlled trial at Prisma Health Midlands on women diagnosed with stage I-I...
Eligibility Criteria
Inclusion
- Eligible participants include adult female patients, ≥18 years of age, with a primary first-time diagnosis of breast cancer, and referred on or after January 1, 2021 for mastectomy surgery.
Exclusion
- Women will be excluded if they will have bilateral surgery, breast-conserving surgery, recurrence of breast cancer, stage IV, or neoadjuvant treatment prior to surgery.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04777786
Start Date
April 1 2021
End Date
March 31 2023
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Carolina
Columbia, South Carolina, United States, 29208